Zheng Li
Department of Pharmacology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China
Zeng-Yan Zuo
Department of Pharmacology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China
Dan-Qing Song
Department of Pharmacology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China
Ying-Hong Li
Department of Pharmacology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China
Jian-Dong Jiang
State Key Laboratory of Bioactive Natural Products and Function, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China
Wei-Jia Kong
Department of Pharmacology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China
PDF Fulltext XML References Citation
How to cite this article
Zheng Li, Zeng-Yan Zuo, Dan-Qing Song, Ying-Hong Li, Jian-Dong Jiang and Wei-Jia Kong, 2016. Berberine Analogue Y53 has Improved Antioxidant and Anti-Inflammatory Activities in Diabetic C57BL/6J Mice with Liver Steatosis. International Journal of Pharmacology, 12: 11-18.
DOI: 10.3923/ijp.2016.11.18
URL: https://scialert.net/abstract/?doi=ijp.2016.11.18
DOI: 10.3923/ijp.2016.11.18
URL: https://scialert.net/abstract/?doi=ijp.2016.11.18